These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 22884837

  • 1. Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: effect of saturation degree.
    Kaialy W, Nokhodchi A.
    Int J Pharm; 2012 Nov 01; 437(1-2):57-69. PubMed ID: 22884837
    [Abstract] [Full Text] [Related]

  • 2. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
    Kaialy W, Martin GP, Larhrib H, Ticehurst MD, Kolosionek E, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2012 Jan 01; 89():29-39. PubMed ID: 21962946
    [Abstract] [Full Text] [Related]

  • 3. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

  • 4. Effect of carrier particle shape on dry powder inhaler performance.
    Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A.
    Int J Pharm; 2011 Dec 12; 421(1):12-23. PubMed ID: 21945739
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.
    Kaialy W, Martin GP, Ticehurst MD, Royall P, Mohammad MA, Murphy J, Nokhodchi A.
    AAPS J; 2011 Mar 12; 13(1):30-43. PubMed ID: 21057906
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
    Kaialy W, Momin MN, Ticehurst MD, Murphy J, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2010 Sep 01; 79(2):345-56. PubMed ID: 20537870
    [Abstract] [Full Text] [Related]

  • 12. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W, Martin GP, Ticehurst MD, Momin MN, Nokhodchi A.
    Int J Pharm; 2010 Jun 15; 392(1-2):178-88. PubMed ID: 20363301
    [Abstract] [Full Text] [Related]

  • 13. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 14. Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations.
    Kaialy W, Nokhodchi A.
    AAPS J; 2013 Jul 01; 15(3):728-43. PubMed ID: 23591748
    [Abstract] [Full Text] [Related]

  • 15. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E, Barrett A, Kraus D, Brody R, Harding L, Magee G.
    Int J Pharm; 2009 Oct 01; 380(1-2):80-8. PubMed ID: 19596428
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
    Kaialy W, Nokhodchi A.
    Int J Pharm; 2013 May 01; 448(1):58-70. PubMed ID: 23500603
    [Abstract] [Full Text] [Related]

  • 18. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H, Markefka P, teWierik H, Kammelar R.
    Int J Pharm; 2006 Feb 17; 309(1-2):51-9. PubMed ID: 16377105
    [Abstract] [Full Text] [Related]

  • 19. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation.
    Chiou H, Li L, Hu T, Chan HK, Chen JF, Yun J.
    Int J Pharm; 2007 Feb 22; 331(1):93-8. PubMed ID: 17052870
    [Abstract] [Full Text] [Related]

  • 20. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN, Robins E, Flament MP.
    Eur J Pharm Biopharm; 2012 Apr 22; 80(3):596-603. PubMed ID: 22198291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.